Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:37 UTC |
---|
HMDB ID | HMDB0014446 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Flucloxacillin |
---|
Description | Flucloxacillin is only found in individuals that have used or taken this drug. It is an antibiotic analog of cloxacillin.By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, flucloxacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that flucloxacillin interferes with an autolysin inhibitor. |
---|
Structure | [H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl)C(O)=O InChI=1S/C19H17ClFN3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | ChEBI | 3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillin | ChEBI | Floxacillin | ChEBI | Floxapen | ChEBI | Flucloxacilina | ChEBI | Flucloxacilline | ChEBI | Flucloxacillinum | ChEBI | MFIPC | Kegg | (2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | Generator | Flucloxacillin-sodium | HMDB | Fluorochloroxacillin | HMDB |
|
---|
Chemical Formula | C19H17ClFN3O5S |
---|
Average Molecular Weight | 453.872 |
---|
Monoisotopic Molecular Weight | 453.056147271 |
---|
IUPAC Name | (2S,5R,6R)-6-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
---|
Traditional Name | flucloxacillin |
---|
CAS Registry Number | 5250-39-5 |
---|
SMILES | [H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl)C(O)=O |
---|
InChI Identifier | InChI=1S/C19H17ClFN3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1 |
---|
InChI Key | UIOFUWFRIANQPC-JKIFEVAISA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as mitomycins. These are polycyclic compounds with a structure based on an aziridine ring linked to a 7-amino-6-methyl-cyclohexa[b]pyrrolizine-5,8-dione. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Indolequinones |
---|
Direct Parent | Mitomycins |
---|
Alternative Parents | |
---|
Substituents | - Mitomycin
- Indole
- Quinone
- Pyrrolizine
- 1,4-diazinane
- Piperazine
- Pyrrolidine
- Vinylogous amide
- Pyrroline
- Ketone
- Aziridine
- Carboximidic acid derivative
- Secondary aliphatic amine
- Enamine
- Azacycle
- Secondary amine
- Primary aliphatic amine
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Imine
- Carbonyl group
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Primary amine
- Amine
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.054 g/L | Not Available | LogP | 3.2 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Flucloxacillin,1TMS,isomer #1 | CC1=C(C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O[Si](C)(C)C)C(C)(C)S[C@H]23)C(C2=C(F)C=CC=C2Cl)=NO1 | 3276.9 | Semi standard non polar | 33892256 | Flucloxacillin,1TMS,isomer #2 | CC1=C(C(=O)N([C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)[Si](C)(C)C)C(C2=C(F)C=CC=C2Cl)=NO1 | 3295.9 | Semi standard non polar | 33892256 | Flucloxacillin,2TMS,isomer #1 | CC1=C(C(=O)N([C@@H]2C(=O)N3[C@@H](C(=O)O[Si](C)(C)C)C(C)(C)S[C@H]23)[Si](C)(C)C)C(C2=C(F)C=CC=C2Cl)=NO1 | 3273.4 | Semi standard non polar | 33892256 | Flucloxacillin,2TMS,isomer #1 | CC1=C(C(=O)N([C@@H]2C(=O)N3[C@@H](C(=O)O[Si](C)(C)C)C(C)(C)S[C@H]23)[Si](C)(C)C)C(C2=C(F)C=CC=C2Cl)=NO1 | 3093.9 | Standard non polar | 33892256 | Flucloxacillin,2TMS,isomer #1 | CC1=C(C(=O)N([C@@H]2C(=O)N3[C@@H](C(=O)O[Si](C)(C)C)C(C)(C)S[C@H]23)[Si](C)(C)C)C(C2=C(F)C=CC=C2Cl)=NO1 | 3939.7 | Standard polar | 33892256 | Flucloxacillin,1TBDMS,isomer #1 | CC1=C(C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)C(C)(C)S[C@H]23)C(C2=C(F)C=CC=C2Cl)=NO1 | 3471.9 | Semi standard non polar | 33892256 | Flucloxacillin,1TBDMS,isomer #2 | CC1=C(C(=O)N([C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)[Si](C)(C)C(C)(C)C)C(C2=C(F)C=CC=C2Cl)=NO1 | 3471.6 | Semi standard non polar | 33892256 | Flucloxacillin,2TBDMS,isomer #1 | CC1=C(C(=O)N([C@@H]2C(=O)N3[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)C(C)(C)S[C@H]23)[Si](C)(C)C(C)(C)C)C(C2=C(F)C=CC=C2Cl)=NO1 | 3593.5 | Semi standard non polar | 33892256 | Flucloxacillin,2TBDMS,isomer #1 | CC1=C(C(=O)N([C@@H]2C(=O)N3[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)C(C)(C)S[C@H]23)[Si](C)(C)C(C)(C)C)C(C2=C(F)C=CC=C2Cl)=NO1 | 3495.8 | Standard non polar | 33892256 | Flucloxacillin,2TBDMS,isomer #1 | CC1=C(C(=O)N([C@@H]2C(=O)N3[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)C(C)(C)S[C@H]23)[Si](C)(C)C(C)(C)C)C(C2=C(F)C=CC=C2Cl)=NO1 | 4067.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Flucloxacillin GC-MS (Non-derivatized) - 70eV, Positive | splash10-006x-9342300000-7f180b75f0b193e6a2bf | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Flucloxacillin GC-MS (1 TMS) - 70eV, Positive | splash10-00di-9101010000-2499cba418eeed4ea1e4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Flucloxacillin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 10V, Negative-QTOF | splash10-03di-0029100000-f63d442cb388e6e6a1fe | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 20V, Negative-QTOF | splash10-03di-0179100000-cc81474beec5e49ab711 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 40V, Negative-QTOF | splash10-03di-2943000000-01ada58e630c1108bd3b | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 10V, Negative-QTOF | splash10-0udi-0030900000-0ee6d1f66c3759d652fe | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 20V, Negative-QTOF | splash10-0f6x-4190100000-fc1930da2cf7aa599457 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 40V, Negative-QTOF | splash10-0006-9170000000-0fa52b5f4e2c50ce52ad | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 10V, Positive-QTOF | splash10-0ika-1980600000-c09913017680462d6167 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 20V, Positive-QTOF | splash10-03dr-1890100000-189280e6a5ebaeff7bcb | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 40V, Positive-QTOF | splash10-0900-3930000000-082278659456539aa269 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 10V, Positive-QTOF | splash10-0udi-0110900000-0d61735c2eb814141c04 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 20V, Positive-QTOF | splash10-0w2i-0590300000-b1e7d7edf8865b92c33a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucloxacillin 40V, Positive-QTOF | splash10-01p9-2590000000-21280c81506029576bdb | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|